Taplin, Mary Ellen
Harvard Medical School,
United States
2025 Rank: 115,352
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3,510 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 115,352 | 125,727 |
| Total Cites | 2,162 | 2,373 |
| H-index | 19 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 60 | 64 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 117 | 127 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,391 | 1,477 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.61 |
| Self-Citation Percentage |
8.89%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2024 Rank: 66,161
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2,150 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66,161 | 69,561 |
| Total Cites | 2,304 | 2,515 |
| H-index | 19 | 21 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 85 | 87 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 159 | 165 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,507 | 1,590 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.58 |
| Self-Citation Percentage |
8.39%
|
|
Taplin, Mary Ellen
Dana-Farber Cancer Institute,
United States
2023 Rank: 56,735
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2,020 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56,735 | 65,321 |
| Total Cites | 2,727 | 3,078 |
| H-index | 22 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 80 | 83 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 168 | 182 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,692 | 1,823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.61 | 1.69 |
| Self-Citation Percentage |
11.40%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2022 Rank: 47,697
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1,808 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47,697 | 48,594 |
| Total Cites | 3,032 | 3,495 |
| H-index | 24 | 25 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 87 | 97 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 182 | 214 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,795 | 1,934 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.81 |
| Self-Citation Percentage |
13.25%
|
|
Taplin, Mary Ellen
Dana-Farber Cancer Institute,
United States
2021 Rank: 47,687
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1,739 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47,687 | 45,034 |
| Total Cites | 4,389 | 5,069 |
| H-index | 26 | 30 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 120 | 136 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 236 | 278 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,654 | 2,863 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.77 |
| Self-Citation Percentage |
13.41%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2020 Rank: 36,014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1,261 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36,014 | 33,477 |
| Total Cites | 3,240 | 3,772 |
| H-index | 23 | 24 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 121 | 134 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 215 | 252 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,976 | 2,137 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.77 |
| Self-Citation Percentage |
14.10%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.